{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T04:11:01Z","timestamp":1747195861110,"version":"3.40.5"},"reference-count":16,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T00:00:00Z","timestamp":1724889600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosmedicine.org"],"crossmark-restriction":false},"short-container-title":["PLoS Med"],"DOI":"10.1371\/journal.pmed.1004449","type":"journal-article","created":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T17:29:12Z","timestamp":1724952552000},"page":"e1004449","update-policy":"https:\/\/doi.org\/10.1371\/journal.pmed.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Using real-world evidence to complement evidence from randomized controlled trials on oral anticoagulants for stroke prevention"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5296-1151","authenticated-orcid":true,"given":"Mark J. R.","family":"Smeets","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4707-2303","authenticated-orcid":true,"given":"Suzanne C.","family":"Cannegieter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2024,8,29]]},"reference":[{"key":"pmed.1004449.ref001","article-title":"Comparative treatment effects of oral anticoagulants for stroke prevention in atrial fibrillation: analysis of routinely collected data with validation against results from a randomised controlled trial.","author":"EM Powell","year":"2024","journal-title":"PLoS Med"},{"key":"pmed.1004449.ref002","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus Warfarin in Patients with Atrial Fibrillation","volume":"365","author":"CB Granger","year":"2011","journal-title":"N Engl J Med"},{"key":"pmed.1004449.ref003","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1161\/CIRCULATIONAHA.107.750000","article-title":"Benefit of Oral Anticoagulant Over Antiplatelet Therapy in Atrial Fibrillation Depends on the Quality of International Normalized Ratio Control Achieved by Centers and Countries as Measured by Time in Therapeutic Range","volume":"118","author":"SJ Connolly","year":"2008","journal-title":"Circulation"},{"key":"pmed.1004449.ref004","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"MR Patel","year":"2011","journal-title":"N Engl J Med"},{"key":"pmed.1004449.ref005","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"SJ Connolly","year":"2009","journal-title":"N Engl J Med"},{"key":"pmed.1004449.ref006","doi-asserted-by":"crossref","first-page":"O53","DOI":"10.1093\/eurheartj\/suaa180","article-title":"Stroke prevention in atrial fibrillation: comparison of recent international guidelines","volume":"22","author":"T-F Chao","year":"2020","journal-title":"Eur Heart J Suppl"},{"volume-title":"Causal Inference: What If","year":"2020","author":"MA Hern\u00e1n","key":"pmed.1004449.ref007"},{"key":"pmed.1004449.ref008","doi-asserted-by":"crossref","first-page":"e0217302","DOI":"10.1371\/journal.pone.0217302","article-title":"The daily practice of direct oral anticoagulant use in patients with atrial fibrillation; an observational cohort study.","volume":"14","author":"AJW Gulpen","year":"2019","journal-title":"PLoS ONE"},{"key":"pmed.1004449.ref009","doi-asserted-by":"crossref","first-page":"4471","DOI":"10.1182\/blood-2007-11-123711","article-title":"Bleeding in patients receiving vitamin K antagonists who would have been excluded from trials on which the indication for anticoagulation was based","volume":"111","author":"M Levi","year":"2008","journal-title":"Blood"},{"key":"pmed.1004449.ref010","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1186\/s13063-015-1023-4","article-title":"A literature review on the representativeness of randomized controlled trial samples and implications for the external validity of trial results.","volume":"16","author":"T Kennedy-Martin","year":"2015","journal-title":"Trials"},{"key":"pmed.1004449.ref011","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1056\/NEJMp2113319","article-title":"Methods of Public Health Research\u2014Strengthening Causal Inference from Observational Data","volume":"385","author":"MA Hern\u00e1n","year":"2021","journal-title":"N Engl J Med"},{"key":"pmed.1004449.ref012","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1002\/cpt.1633","article-title":"Nonrandomized Real-World Evidence to Support Regulatory Decision Making: Process for a Randomized Trial Replication Project","volume":"107","author":"JM Franklin","year":"2020","journal-title":"Clin Pharmacol Ther"},{"key":"pmed.1004449.ref013","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1002\/cpt.2083","article-title":"Randomized Controlled Trials Versus Real World Evidence: Neither Magic Nor Myth","volume":"109","author":"H-G Eichler","year":"2021","journal-title":"Clin Pharmacol Ther"},{"key":"pmed.1004449.ref014","doi-asserted-by":"crossref","first-page":"e213845","DOI":"10.1001\/jamanetworkopen.2021.3845","article-title":"Trial Emulation and Real-World Evidence","volume":"4","author":"RHH Groenwold","year":"2021","journal-title":"JAMA Netw Open"},{"key":"pmed.1004449.ref015","first-page":"1376","article-title":"RCT-DUPLICATE Initiative. Emulation of Randomized Clinical Trials With Nonrandomized Database Analyses: Results of 32","volume":"329","author":"SV Wang","year":"2023","journal-title":"Clinical Trials. JAMA"},{"year":"2021","author":"NICE","article-title":"Recommendations | Atrial fibrillation: diagnosis and management | Guidance","key":"pmed.1004449.ref016"}],"container-title":["PLOS Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1004449","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T17:29:19Z","timestamp":1724952559000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1004449"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,29]]},"references-count":16,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2024,8,29]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pmed.1004449","relation":{},"ISSN":["1549-1676"],"issn-type":[{"type":"electronic","value":"1549-1676"}],"subject":[],"published":{"date-parts":[[2024,8,29]]}}}